期刊文献+

探讨高通量血透对维持性透析患者血清叶酸、维生素B12水平影响 被引量:4

Effects of high flux hemodialysis on serum level of folate and vitamin B12 in maintenance hemodialysis patients
原文传递
导出
摘要 目的研究高通量血液透析(high flux hemodialysis,HFD)对维持性血液透析(maintain hemodialysis,MHD)患者血清叶酸(Fol)、维生素B12(VitB12)及部分生化指标影响。方法采用前瞻性、自身对照研究,本组44例为常规低通量血液透析(low flux hemodialysis,LFH)患者,转换为HFD治疗1年。单因素方差分析比较透析前、透析后6、12个月透析前Fol、VitB12、Hb、Hct、Cr、BUN、P、Ca、iPTH、ALB、CRP等指标的变化。结果 HFD后6、12个月较LFD时VitB12、Fol有显著升高,差异有统计学意义(P均<0.05);BUN、Cr、Ca等生化指标在转化为HFD后,与LFD时比较,差异无统计学意义(P>0.05);但CRP、iPTH、P、Hb、Hct等指标在两种透析状态下有明显不同,差异有统计学意义(P<0.05)。结论 HFD治疗后Fol、VitB12有增加趋势,进而改善贫血和营养不良,可能会提高血液透析病人的生存质量。 Objective To study the effects of high flux hemodialysis (HFD) on serum level of folate and vitamin B12 in hemodialysis patients. Methods This was a perspective and self-controlled study. A total of 44 patients on maintenance low flux hemodialysis (LFD) were selected. The serum levels of Fol, VitB12, Cr, BUN, P, Ca, iPTH, ALB, CRP, Hb, Hct% level before changing to HFD and after 6, 12 months entering this study were respectively analyzed by One-way ANOVA. Results The differences of serum levels of Fol, VitB12 were significant before and 6,12 months after entering into the study (FFol=3.371, P〈 0.05,FVitb12=5.676, P〈 0.05). And there were differences of CRP、 iPTH、P、Hb、Hct% before and 6, 12 months after entering into the study(P〈0.05). But the differences of Cr, BUN, Ca were not significant before and after changing to HFD (P 〉 0.05). Conclusion The study has shown that HFD can increase the serum levels of Fol and vitB12, probably improve anemia, malnutrition and life quality of hemodialysis patients.
出处 《北京医学》 CAS 2014年第7期537-539,共3页 Beijing Medical Journal
  • 相关文献

参考文献7

二级参考文献34

  • 1YoshitioM, Kuhlmann MK, Kotanko P, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality [J]. J Am Soc Nephrol, 2006, 17: 3510-3519.
  • 2Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability[J]. Kidney Int, 2003, 63:1934- 1943.
  • 3Vanholder R, Meert N, Schepers E, et al. Uremic toxins: Do we know enough to explain uremia[J]. Blood Purif, 2008, 26: 77-81.
  • 4Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identi fled as beta 2 microglobulin[J]. Biochem Biophys Res Commun, 1985, 129:701 -706.
  • 5Bember LM, Jaber BL. Dialysis- ReLated Amyloidosis: Late Finding or Hidden Epidemic[J]. Seminars in Dialysis, 2006, 19:105-109.
  • 6Cheung AK, Rocco MV, gan G, et al. Serum β2- microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J]. J Am Soc Nephrol, 2006, 17:546- 555.
  • 7Okuno S, Ishimura E, Rohno K, et al. Serum β2-microglobulin level is a significant predictor of mortality in mainte nance haemodialysis patients[J]. Nephrol Diat Transplant, 2009, 24: 571-577.
  • 8Nakai S, Iseki K, Tabei K, et al. Outcomes of hermdiafiltration based on Japanese dialysis patient registry[J]. Am J Kidney Disease, 2001, 38: S212-216.
  • 9Furuya R, Kumaqai B, Takahashi M, et al. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients[J]. Blood Purif, 2005,23:311- 316.
  • 10Masakane I. Review: Clinical usefulness of ultrapure diaiysate -recent evidence and perspectives[J]. Ther Apher Dial, 2006, 10: 348-354.

共引文献252

同被引文献39

  • 1陈伟,崔天蕾,谢林伸,李昕怡,吴敬.不同血液净化方式对维持性血液透析患者微炎症状态和营养状态的影响[J].中国老年学杂志,2015,35(2):379-380. 被引量:45
  • 2张冬.全国血液透析病例信息登记系统的建立及血液透析患者贫血治疗情况分析[D].北京:军医进修学院解放军总医院,2012.
  • 3Schneider A, Drechsler C, Krane V,et al. The effect of high - flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS study[ J]. Clin J Am SocNephrol, 2012,7(1) : 52 -59.
  • 4Tatteall J, Canaud B, Heimburger O, et al. European Renal Best Practice advisory Board. High - flux or low - flux dialysis : a position statement following publication of the MembranePerme- ability outcome study. [ J ] Nephrol Dial Transplant, 2010, 25 (4) :1230 - 1232.
  • 5KDOQI. Clinical practice guideline and clinical practice recom- mendations for anemia in chronic kidney disease: 2007 update of hemoglobin target [ J ]. Am J Kidney Disease, 2007,50 ( 3 ) : 471 - 530.
  • 6Demirei MS, Demirei C, Ozdogan O, et al. Relations between malnutrition - inflammation - atherosclerosis and volume status : the usefulness of bioimpedanee analysis in peritoneal dialysis pa- tients [ J ]. Nephrol Dial Transplant, 2011,26 ( 5 ) : 1708 - 1716.
  • 7Chen J, Gul A, Samak MJ. Management of intradialytie hyperten- sion: the ongoing challenge. Semin Dial, 2006, 19 ( 2 ) : 141 - 145.
  • 8Dupuy AM,Terrier N,Senecal Let al. Is C - reactive protein a marker of inflammation? Nephrologie ,2008,24(7 ) :337 - 341.
  • 9Kim KI, Lee JH, Chang 1 - 1J, et al. Association between blood pressure variability and inflammatory marker in hypertensive pa- tients. Circ J,2008,72 ( 2 ) : 293 - 298.
  • 10Moshfegh A, Jacobson SH, Halld6n G, et al. Impact of hemodialy- sis membrane and permeability on neutrophil transmigration in vitro. Nephron,2002,91 (4) :659 - 665.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部